Hepatitis B situation
Hepatitis B is a global health problem. The rate and number of people with hepatitis B are very high. An estimated 2 billion people have been infected with hepatitis B. More than 300 million people are chronically infected.
HBV infection a truly silent epidemic.
Chronic hepatitis B is the leading cause of cirrhosis and liver cancer.
The hepatitis b controlling medication is available but currently there is no cure for chronic hepatitis B. There have been many drugs for hepatitis B treatment.
The latest drug for chronic hepatitis B
At the end of 2016, the US Food and Drug Administration (FDA) has recognized Tenofovir Alafenamide (TAF) as a new drug to treat chronic hepatitis B.
The advantage of this drug is that the effectiveness of viral suppression B is very good but causes fewer side effects than Tenofovir disoproxil fumarate (TDF).
Outstanding advantages of the latest drug Tenofovir Alafenamide (TAF) treatment of chronic hepatitis B:
In 2017, Gilead Pharmaceutical Company (USA) has also allowed Indian pharmaceutical companies to produce generic version of Tenofovir Alafenamide (TAF) with reasonable prices for low and middle income countries to help patients in this country will soon have access to new drugs.
HepBest 25mg (Generic Vemlidy) Tenofovir Alafenamide 25 mg in India
HepBest (Tenofovir alafenamide 25 mg) was produced at pharmaceutical company: Mylan Laboratories Limited, India.
Mylan produces HepBest 25mg (TAF), a new hepatitis B drug.
Product Name: HepBest
Generic name: Tenofovir Alafenamide
Pharmaceutical composition: Tenofovir Alafenamide
Dosage form: tablet
Specifications: 30 tablets * 25mg
Usage and Dosage: The recommended dose is 25mg/day, once a day.
Some information you need to know about the drug: HepBest
1. Composition and HepBest quality
Each film-coated tablet contains: Tenofovir Alafenamide fumarate equivalent to Tenofovir Alafenamide 25 mg
2. Processing from HepBest
White or white oblong-shaped tablets with an M on one side and TFI on the other
3. Indications to use HepBest 25mg
HepBest – Tenofovir Alafenamide 25 mg is indicated for the treatment of chronic hepatitis B.
Although HepBest can control viral replication, it can’t completely cure hepatitis B, HepBest is also authorized generic drug.
The efficacy is the same as the original drug, there is no research and development costs, the price is far lower than the original drug, the patient has no economic burden for long-term use.
The two TAF drugs produced in India are HepBest 25mg produced by Mylan company and Tafnat 25mg by Natco pharma company.
HepBest is the generic product of tenofovir II (TAF) produced by Mylan
Treat hepatitis B early to prevent progression to cirrhosis and liver cancer.
Currently Entavir generic Entecavir and Tenofovir Alafenamide (TAF) are still the two drugs that are most effective in treating hepatitis B but have not completely eliminated the virus.
HepBest 25mg price in India
The cost of HepBest Indian generic Tenofovir Alafenamide TAF is very low as compare to International brand.
What are the top popular Indian generic Tenofovir Alafenamide hepatitis B drugs?
HepBest (Tenofovir Alafenamide TAF) manufactured by MyLan laboratories Ltd, India and Tafnat Tenofovir Alafenamide (TAF) manufactured by Natco pharma Limited, India are popular.